Pamela Stephenson

Track

Insider profile

Currently holds positions in Albireo Pharma Inc and Zynerba Pharmaceuticals Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Commercial Officer Albireo Pharma Inc March 25, 2019 -
Independent Director Zynerba Pharmaceuticals Inc Feb. 19, 2019 -
Pamela Stephenson's trades of Disc Medicine, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
486.19
Quantity 42,427 +28.3%
Value US$930,233
Transaction date
Proposed sale
Price
363.39
Quantity 64,697
Value US$4,799,443
Transaction date
Sale
Price
401.01
Quantity 37,832 +12.7%
Value US$4,630,267
Transaction date
Planned sale
Price
43.80
Quantity 102 -0.2%
Value US$4,468
Transaction date
Planned sale
Price
43.90
Quantity 1,774 -4.0%
Value US$77,886
Transaction date
Planned sale
Price
19.06
Quantity 469 -1.0%
Value US$8,940
Transaction date
Planned sale
Price
19.58
Quantity 104 -0.2%
Value US$2,036
Transaction date
Planned sale
Price
19.40
Quantity 445 -1.0%
Value US$8,635
Transaction date
Planned sale
Price
24.67
Quantity 106 -0.2%
Value US$2,615
Transaction date
Planned sale
Price
19.47
Quantity 461 -1.0%
Value US$8,976
Transaction date
Planned sale
Price
32.92
Quantity 103 -0.2%
Value US$3,391
Transaction date
Planned sale
Price
30.53
Quantity 454 -1.0%
Value US$13,858
Transaction date
Planned sale
Price
24.88
Quantity 416 -0.9%
Value US$10,351
Transaction date
Planned sale
Price
32.05
Quantity 451 -1.7%
Value US$14,456
Transaction date
Planned sale
Price
36.01
Quantity 471 -1.7%
Value US$16,961
Transaction date
Planned sale
Price
39.07
Quantity 460 -2.1%
Value US$17,974
Transaction date
Planned sale
Price
33.20
Quantity 451 -2.0%
Value US$14,973
Transaction date
Planned sale
Price
30.79
Quantity 397 -1.7%
Value US$12,224
Transaction date
Planned sale
Price
17.60
Quantity 1,785 -7.1%
Value US$31,416
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-17 2026-02-17
S Sale
42,427 +28.3%
486.19
US$930,233 		42,427 +28.3% 486.19 US$930,233
2026-02-17 2026-02-17
PrS Proposed sale
64,697
363.39
US$4,799,443 		64,697 363.39 US$4,799,443
2025-02-20 2025-02-18
S Sale
37,832 +12.7%
401.01
US$4,630,267 		37,832 +12.7% 401.01 US$4,630,267
2023-06-15 2023-06-14
S Sale
115 -0.2%
0.35
US$40 		115 -0.2% 0.35 US$40
2023-01-23 2023-01-23
PlS Planned sale
102 -0.2%
43.80
US$4,468 		102 -0.2% 43.80 US$4,468
2023-01-20 2023-01-19
PlS Planned sale
1,774 -4.0%
43.90
US$77,886 		1,774 -4.0% 43.90 US$77,886
2022-12-27 2022-12-27
PlS Planned sale
469 -1.0%
19.06
US$8,940 		469 -1.0% 19.06 US$8,940
2022-10-25 2022-10-24
PlS Planned sale
104 -0.2%
19.58
US$2,036 		104 -0.2% 19.58 US$2,036
2022-09-27 2022-09-26
PlS Planned sale
445 -1.0%
19.40
US$8,635 		445 -1.0% 19.40 US$8,635
2022-07-25 2022-07-22
PlS Planned sale
106 -0.2%
24.67
US$2,615 		106 -0.2% 24.67 US$2,615
2022-06-28 2022-06-27
PlS Planned sale
461 -1.0%
19.47
US$8,976 		461 -1.0% 19.47 US$8,976
2022-06-16 2022-06-14
S Sale
40 -0.1%
1.01
US$40 		40 -0.1% 1.01 US$40
2022-04-25 2022-04-22
PlS Planned sale
103 -0.2%
32.92
US$3,391 		103 -0.2% 32.92 US$3,391
2022-03-29 2022-03-28
PlS Planned sale
454 -1.0%
30.53
US$13,858 		454 -1.0% 30.53 US$13,858
2022-01-25 2022-01-24
PlS Planned sale
416 -0.9%
24.88
US$10,351 		416 -0.9% 24.88 US$10,351
2021-09-28 2021-09-27
PlS Planned sale
451 -1.7%
32.05
US$14,456 		451 -1.7% 32.05 US$14,456
2021-06-28 2021-06-25
PlS Planned sale
471 -1.7%
36.01
US$16,961 		471 -1.7% 36.01 US$16,961
2020-12-29 2020-12-28
PlS Planned sale
460 -2.1%
39.07
US$17,974 		460 -2.1% 39.07 US$17,974
2020-09-25 2020-09-25
PlS Planned sale
451 -2.0%
33.20
US$14,973 		451 -2.0% 33.20 US$14,973
2020-06-26 2020-06-25
PlS Planned sale
397 -1.7%
30.79
US$12,224 		397 -1.7% 30.79 US$12,224
2020-03-25 2020-03-25
PlS Planned sale
1,785 -7.1%
17.60
US$31,416 		1,785 -7.1% 17.60 US$31,416